Third-line therapies in patients with Kawasaki disease refractory to first- and second-line intravenous immunoglobulin therapy

被引：0
|
作者：
Takashi Furuta
Hiroki Yasudo
Seigo Okada
Yuji Ohnishi
Akiko Kawakami-Miyake
Yasuo Suzuki
Shouichi Ohga
Shunji Hasegawa
机构：
[1] Yamaguchi University Graduate School of Medicine,Department of Pediatrics
[2] Kyushu University,Department of Pediatrics, Graduate School of Medical Sciences
来源：
World Journal of Pediatrics | 2022年 / 18卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：781 / 785
页数：4
相关论文
共 50 条
  • [1] Third-line therapies in patients with Kawasaki disease refractory to first- and second-line intravenous immunoglobulin therapy
    Furuta, Takashi
    Yasudo, Hiroki
    Okada, Seigo
    Ohnishi, Yuji
    Kawakami-Miyake, Akiko
    Suzuki, Yasuo
    Ohga, Shouichi
    Hasegawa, Shunji
    WORLD JOURNAL OF PEDIATRICS, 2022, 18 (11) : 781 - 785
  • [2] Combination of prednisolone and cyclosporine A as third-line therapy for refractory Kawasaki disease
    Higashigawa, Masamune
    Nakamura, Tomomi
    Hattori, Tomoki
    Yoshino, Ayako
    Ito, Mitsue
    Ichimi, Ryoji
    MINERVA PEDIATRICS, 2023, 75 (05): : 682 - 688
  • [3] Second-line failure and first experience with third-line antiretroviral therapy in Mumbai, India
    Khan, Samsuddin
    Das, Mrinalini
    Andries, Aristomo
    Deshpande, Alaka
    Mansoor, Homa
    Saranchuk, Peter
    Isaakidis, Petros
    GLOBAL HEALTH ACTION, 2014, 7 : 1 - 6
  • [4] Therapy of malignant melanoma. First-, second- and pathogenesis-oriented third-line therapies
    Rass, K.
    Tadler, D.
    Tilgen, W.
    HAUTARZT, 2006, 57 (09): : 773 - +
  • [5] Plasma exchange and infliximab as a third-line therapy for refractory infantile Kawasaki disease
    Ansai, Hideto
    Masuda, Hiroshi
    Nakao, Hiro
    Nishimura, Nao
    Kubota, Mitsuru
    PEDIATRICS INTERNATIONAL, 2022, 64 (01)
  • [6] Treatment of autoimmune hepatitis—First-line, second-line and third-line treatment
    Taubert R.
    Engel B.
    Die Innere Medizin, 2024, 65 (4) : 325 - 333
  • [7] INTRAVENOUS IMMUNOGLOBULIN AS A THIRD-LINE THERAPY IN CHRONIC SPONTANEOUS URTICARIA
    Mitzel-Kaoukhov, Heidrun
    Staubach, Petra
    Mueller-Brenne, Tina
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2010, 105 (03) : 245 - 246
  • [8] Comprehensive analysis of lung adenocarcinoma patients with gefitinib as first-line, second-line and third-line treatment
    Liu, Daoming
    Wang, Fei
    Chen, Xia
    Shi, Hong
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (10): : 20171 - 20178
  • [9] Docetaxel in the first- and second-line therapy of gastric cancer
    Vanhoefer, U
    ONKOLOGIE, 2000, 23 : 40 - 42
  • [10] First- and second-line therapy of metastatic colorectal cancer
    Terstriep, Shelby
    Grothey, Axel
    EXPERT REVIEW OF ANTICANCER THERAPY, 2006, 6 (06) : 921 - 930
12345